What is the main business of Zakład Patomorfologii Alfamed?

The main business activity of Zakład Patomorfologii Alfamed focuses on independent medical laboratory activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 29, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Jana Kilińskiego 78, 22-400 Zamość.

Who is on the management board?

The management board consists of: Agnieszka Szydłowska (Member of the Management Board), Tomasz Marek Barski (Member of the Management Board), and Grzegorz Marcin Wędrychowicz (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $4,020,861 in 2025, which is an increase of 29.5% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $725,263, meaning the company decreased its profit by 29.6%.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $934,177 in 2025, representing 34% of all operating expenses.

Zakład Patomorfologii Alfamedsp. z o.o.

Independent medical laboratory activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-03-29

Share capital

100 000,00 PLN

Activity description

Zakład Patomorfologii Alfamed is a pathology laboratory that offers diagnostic services including liquid cytology using BD SurePath™ and HPV DNA testing with BD Onclarity™. The company provides tools for diagnostic results and collaborates with various partners in the healthcare sector.

Registered address

ul. Jana Kilińskiego 78, 22-400 Zamość, Poland

Website

alfamed.biz

Phone

Electronic delivery address

AE:PL-79079-84741-DRVIF-19

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.02mMedianUSD 1.19mAverageUSD 20.98m

Net profit

This companyUSD 725.26kMedianUSD 101.78kAverageUSD 1.28m

Operating costs

This companyUSD 2.78mMedianUSD 1.08mAverageUSD 18.94m

Assets

This companyUSD 1.25mMedianUSD 1.07mAverageUSD 11.99m

Industry

Bank accounts

Registered as a VAT taxpayer on 2024-10-31. Active

mBank
05 1140 0039 0000 7067 5500 1002
mBank
32 1140 0039 0000 7067 5500 1001
mBank
75 1140 0039 0000 7067 5500 1003

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

15 public aid cases recorded, with a total value of $136,463.

Grant date	Purpose	Gross amount	Granting body
Oct 19, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,196$1,196	Prezes Banku Gospodarstwa Krajowego
Oct 19, 2021	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,380$1,380	Prezes Banku Gospodarstwa Krajowego
Oct 19, 2020	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,368$1,368	Prezes Banku Gospodarstwa Krajowego

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Agnieszka Szydłowska — Management Board Member

Tomasz Marek Barski — Management Board Member

Grzegorz Marcin Wędrychowicz — Management Board Member

Manner of representation

If a multi-member management board is appointed, each member of the management board may make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
NU-MED Centrum Diagnostyki I Terapii Onkologicznej Zamość sp. z o.o.	2,000	$27,012.43	100%

Beneficial owners

Person	Rights
Ségolène Francine M Frère (49)	Osoba fizyczna sprawująca kontrolę nad osobą prawną, której przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów

Competitors

Name	Revenue	Website
Testdnasp. z o.o.	$4,995,818.97	testdna.pl
Med-Alkosp. z o.o.	$4,975,214.03	medalko.pl
Tres-MEDsp. z o.o.	$4,853,535.89	tres-med.pl
Zdrowiesp. z o.o.	$4,731,112.09	zpzdrowie.pl
Niepubliczny Zakład Opieki Zdrowotnej Zakład Pulmonologiisp. z o.o.	$4,695,971.39	pulmo.pl
Genossp. z o.o.	$3,695,996.40	genos.com.pl
Centermed Poznańsp. z o.o.	$3,656,726.26	centermed.pl
Warsaw GenomicsS.A.	$3,563,297.87	warsawgenomics.pl
Info-Pat sp. z o.o.sp. k.	$1,930,368.97	info-pat.poznan.pl
Masdiagsp. z o.o.	$1,691,863.39	masdiag.pl

FAQ

Last updated: 2026-07-15